{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:08:29Z","timestamp":1789772909369,"version":"4.0.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["autonomicneuroscience.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autonomic Neuroscience"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.autneu.2021.102859","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T23:24:25Z","timestamp":1627687465000},"page":"102859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The discovery and development of gefapixant"],"prefix":"10.1016","volume":"235","author":[{"given":"Anthony P.","family":"Ford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Kitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel R.","family":"Gever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9974","key":"10.1016\/j.autneu.2021.102859_bb0005","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0140-6736(14)61255-1","article-title":"P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study","volume":"385","author":"Abdulqawi","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.autneu.2021.102859_bb0010","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1378\/chest.128.4.1905","article-title":"Effects of aerosolized adenosine 5\u2019-triphosphate vs adenosine 5\u2019-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma","volume":"128","author":"Basoglu","year":"2005","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.autneu.2021.102859_bb0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1113\/jphysiol.2003.044172","article-title":"Peristalsis is impaired in the small intestine of mice lacking the P2X3 subunit","volume":"551","author":"Bian","year":"2003","journal-title":"J. Physiol."},{"issue":"1\u20132","key":"10.1016\/j.autneu.2021.102859_bb0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-2999(99)00350-7","article-title":"Pharmacological characterization of recombinant human and rat P2X receptor subtypes","volume":"376","author":"Bianchi","year":"1999","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.autneu.2021.102859_bb0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0014-5793(95)01203-Q","article-title":"A P2X purinoceptor cDNA conferring a novel pharmacological profile","volume":"375","author":"Bo","year":"1995","journal-title":"FEBS Lett."},{"issue":"4\u20135","key":"10.1016\/j.autneu.2021.102859_bb0035","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1006\/mcne.1998.0719","article-title":"The expression of P2X3 purinoceptors in sensory neurons: effects of axotomy and glial-derived neurotrophic factor","volume":"12","author":"Bradbury","year":"1998","journal-title":"Mol. Cell. Neurosci."},{"issue":"6497","key":"10.1016\/j.autneu.2021.102859_bb0040","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/371519a0","article-title":"New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor","volume":"371","author":"Brake","year":"1994","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.autneu.2021.102859_bb0045","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0031-6997(25)06930-3","article-title":"Purinergic nerves","volume":"24","author":"Burnstock","year":"1972","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.autneu.2021.102859_bb0050","series-title":"Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach","first-page":"107","article-title":"A basis for distinguishing two types of purinergic receptor","author":"Burnstock","year":"1978"},{"key":"10.1016\/j.autneu.2021.102859_bb0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/bs.apha.2015.09.001","article-title":"Purinergic mechanisms and pain","volume":"75","author":"Burnstock","year":"2016","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.autneu.2021.102859_bb0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bcp.2017.07.016","article-title":"The therapeutic potential of purinergic signalling","volume":"151","author":"Burnstock","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.autneu.2021.102859_bb0065","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0306-3623(85)90001-1","article-title":"Is there a basis for distinguishing two types of P2- purinoceptor?","volume":"16","author":"Burnstock","year":"1985","journal-title":"Gen. Pharmacol."},{"issue":"3","key":"10.1016\/j.autneu.2021.102859_bb0070","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1476-5381.1972.tb07283.x","article-title":"Atropine resistant excitation of the urinary bladder: the possibility of transmission via nerves releasing a purine nucleotide","volume":"44","author":"Burnstock","year":"1972","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.autneu.2021.102859_bb0075","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1124\/pr.111.005389","article-title":"Purinergic signaling in the airways","volume":"64","author":"Burnstock","year":"2012","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.autneu.2021.102859_bb5000","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1378\/chest.14-1481","article-title":"CHEST expert cough panel. Anatomy and neurophysiology of cough: CHEST guideline and expert panel report","volume":"146","author":"Canning","year":"2014","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.autneu.2021.102859_bb0080","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bmcl.2009.02.003","article-title":"Identification and SAR of novel diaminopyrimidines. part 1: the discovery of RO-4, a dual P2X3\/P2X2\/3 antagonist for the treatment of pain","volume":"19","author":"Carter","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.autneu.2021.102859_bb0085","series-title":"P2 Purinoceptors: Localization, Function and Transduction Mechanisms: Ciba Foundation Symposium #198","author":"Chadwick","year":"1996"},{"issue":"6548","key":"10.1016\/j.autneu.2021.102859_bb0090","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/377428a0","article-title":"A P2X purinoceptor expressed by a subset of sensory neurons","volume":"377","author":"Chen","year":"1995","journal-title":"Nature"},{"issue":"6807","key":"10.1016\/j.autneu.2021.102859_bb0095","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/35039519","article-title":"Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice","volume":"407","author":"Cockayne","year":"2000","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.autneu.2021.102859_bb0100","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1113\/jphysiol.2005.088435","article-title":"P2X2 knockout mice and P2X2\/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP","volume":"567","author":"Cockayne","year":"2005","journal-title":"J. Physiol."},{"issue":"8","key":"10.1016\/j.autneu.2021.102859_bb0105","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1523\/JNEUROSCI.16-08-02495.1996","article-title":"Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels","volume":"16","author":"Collo","year":"1996","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.autneu.2021.102859_bb0110","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1124\/pr.111.005116","article-title":"Antitussive drugs\u2013past, present, and future","volume":"66","author":"Dicpinigaitis","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.autneu.2021.102859_bb0115","series-title":"Tetrazole-substituted Arylamides as P2X3 and P2X2\/3 Antagonists. US 2008\/0004442 A1","author":"Dillon","year":"2008"},{"issue":"3","key":"10.1016\/j.autneu.2021.102859_bb0120","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1113\/jphysiol.1929.sp002608","article-title":"The physiological activity of adenine compounds with especial reference to their action upon mammalian heart","volume":"68","author":"Drury","year":"1929","journal-title":"J. Physiol."},{"issue":"2","key":"10.1016\/j.autneu.2021.102859_bb0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0301-0082(01)00005-3","article-title":"P2X receptors in peripheral neurons","volume":"65","author":"Dunn","year":"2001","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.autneu.2021.102859_bb0130","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.4049\/jimmunol.159.3.1451","article-title":"Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages","volume":"159","author":"Ferrari","year":"1997","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.autneu.2021.102859_bb0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0026-895X(25)08672-9","article-title":"Expression of a cloned P2Y purinergic receptor that couples to phospholipase C","volume":"46","author":"Filtz","year":"1994","journal-title":"Mol. Pharmacol."},{"issue":"5753","key":"10.1016\/j.autneu.2021.102859_bb0140","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1126\/science.1118435","article-title":"ATP signaling is crucial for communication from taste buds to gustatory nerves","volume":"310","author":"Finger","year":"2005","journal-title":"Science"},{"issue":"Suppl. 1","key":"10.1016\/j.autneu.2021.102859_bb0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11302-011-9271-6","article-title":"In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization","volume":"8","author":"Ford","year":"2012","journal-title":"Purinergic Signal"},{"issue":"3","key":"10.1016\/j.autneu.2021.102859_bb0150","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2217\/pmt.12.16","article-title":"P2X3 antagonists: novel therapeutics for afferent sensitization and chronic pain","volume":"2","author":"Ford","year":"2012","journal-title":"Pain Manag."},{"key":"10.1016\/j.autneu.2021.102859_bb0155","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/978-3-642-16499-6_22","article-title":"ATP and P2X purinoceptors in urinary tract disorders","volume":"202","author":"Ford","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.autneu.2021.102859_bb0160","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fncel.2013.00267","article-title":"The therapeutic promise of ATP antagonism at P2X3 receptors in respiratory and urological disorders","volume":"7","author":"Ford","year":"2013","journal-title":"Front. Cell. Neurosci."},{"issue":"Suppl. 2","key":"10.1016\/j.autneu.2021.102859_bb0165","first-page":"S132","article-title":"Purinoceptors as therapeutic targets for lower urinary tract dysfunction","volume":"147","author":"Ford","year":"2006","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.autneu.2021.102859_bb0170","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.autneu.2015.04.005","article-title":"P2X3 receptors and sensitization of autonomic reflexes","volume":"191","author":"Ford","year":"2015","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.autneu.2021.102859_bb0175","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pupt.2019.03.007","article-title":"BLU-5937: a selective P2X3 antagonist with potent anti-tussive effect and no taste alteration","volume":"56","author":"Garceau","year":"2019","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.autneu.2021.102859_bb0180","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00424-006-0070-9","article-title":"Pharmacology of P2X channels","volume":"452","author":"Gever","year":"2006","journal-title":"Pflugers Arch."},{"issue":"6","key":"10.1016\/j.autneu.2021.102859_bb0185","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1476-5381.2010.00796.x","volume":"160","author":"Gever","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.autneu.2021.102859_bb0190","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.bmcl.2018.02.039","article-title":"Identification of second-generation P2X3 antagonists for treatment of pain","volume":"28","author":"Ginnetti","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.autneu.2021.102859_bb0195","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1080\/17476348.2020.1811686","article-title":"Looking ahead to novel therapies for chronic cough. Part 1 \u2013 peripheral sensory nerve targeted treatments","volume":"14","author":"Grabczak","year":"2020","journal-title":"Expert Rev. Respir. Med."},{"issue":"3","key":"10.1016\/j.autneu.2021.102859_bb0200","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/bph.15299","article-title":"Update of P2X receptor properties and their pharmacology: IUPHAR review 30","volume":"178","author":"Illes","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"19","key":"10.1016\/j.autneu.2021.102859_bb0205","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1021\/jm020046y","article-title":"Purine and pyrimidine (P2) receptors as drug targets","volume":"45","author":"Jacobson","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.autneu.2021.102859_bb0210","article-title":"Medicinal chemistry of P2 and adenosine receptors: common scaffolds adapted for multiple targets","author":"Jacobson","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.autneu.2021.102859_bb0215","doi-asserted-by":"crossref","first-page":"17179","DOI":"10.1073\/pnas.252537299","article-title":"A-317491, a novel, potent and selective non-nucleotide antagonist of P2X3 and P2X2\/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat","volume":"99","author":"Jarvis","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20133","key":"10.1016\/j.autneu.2021.102859_bb0220","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2006.07.034","article-title":"Involvement of ionotropic purinergic receptors in the histamine-induced enhancement of the cough reflex sensitivity in Guinea pigs","volume":"547","author":"Kamei","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.autneu.2021.102859_bb0225","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejphar.2005.10.030","article-title":"Involvement of P2X receptor subtypes in ATP-induced enhancement of the cough reflex sensitivity","volume":"528","author":"Kamei","year":"2005","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.autneu.2021.102859_bb0230","doi-asserted-by":"crossref","first-page":"L858","DOI":"10.1152\/ajplung.90360.2008","article-title":"P2X2 receptors differentiate placodal vs. neural crest C-fiber phenotypes innervating Guinea pig lungs and esophagus","volume":"295","author":"Kwong","year":"1999","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"1\u20133","key":"10.1016\/j.autneu.2021.102859_bb0235","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0165-1838(00)00120-X","article-title":"Regulated expression of the rat recombinant P2X3 receptor in stably transfected CHO-K1 tTA cells","volume":"81","author":"Lachnit","year":"2000","journal-title":"J. Auton. Nerv. Syst."},{"issue":"6548","key":"10.1016\/j.autneu.2021.102859_bb0240","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/377432a0","article-title":"Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons","volume":"377","author":"Lewis","year":"1995","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.autneu.2021.102859_bb0245","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0022-3565(24)38849-4","article-title":"Coexpression of P2X3 and P2X2 receptor subunits in varying amounts generates heterogeneous populations of P2X receptors that evoke a spectrum of agonist responses comparable to that seen in sensory neurons","volume":"296","author":"Liu","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"10.1016\/j.autneu.2021.102859_bb0250","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1164\/rccm.200910-1506OC","article-title":"Extracellular adenosine triphosphate and chronic obstructive pulmonary disease","volume":"181","author":"Lommatzsch","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7623","key":"10.1016\/j.autneu.2021.102859_bb0255","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/nature19367","article-title":"X-ray structures define human P2X3 receptor gating cycle and antagonist action","volume":"538","author":"Mansoor","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.autneu.2021.102859_bb0260","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1152\/physrev.00039.2015","article-title":"Vagal afferent innervation of the airways in health and disease","volume":"96","author":"Mazzone","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.autneu.2021.102859_bb0265","first-page":"3800","article-title":"Two phase 3 randomized clinical trials of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough (COUGH-1 and COUGH-2)","volume":"56","author":"McGarvey","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.autneu.2021.102859_bb0270","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/tx200211v","article-title":"Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety","volume":"24","author":"Meanwell","year":"2011","journal-title":"Chem. Res. Toxicol."},{"issue":"4","key":"10.1016\/j.autneu.2021.102859_bb0280","doi-asserted-by":"crossref","first-page":"00284","DOI":"10.1183\/23120541.00284-2020","article-title":"Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough","volume":"6","author":"Muccino","year":"2020","journal-title":"ERJ Open Res."},{"issue":"3","key":"10.1016\/j.autneu.2021.102859_bb0285","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.coph.2011.05.006","article-title":"Targeting peripheral afferent nerve terminals for cough and dyspnea","volume":"11","author":"Muroi","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.autneu.2021.102859_bb0290","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/sj.bjp.0705411","article-title":"2\u2019,3\u2019-O-(2,4,6, trinitrophenyl)-ATP and A-317491 are competitive antagonists at a slowly desensitizing chimeric human P2X3 receptor","volume":"140","author":"Neelands","year":"2003","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.autneu.2021.102859_bb0295","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1073\/pnas.91.8.3275","article-title":"Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy","volume":"91","author":"Parr","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.autneu.2021.102859_bb0300","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pupt.2019.03.002","article-title":"Targeting C-fibers for peripheral acting anti-tussive drugs","volume":"56","author":"Patil","year":"2019","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"Pt 3","key":"10.1016\/j.autneu.2021.102859_bb0305","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1113\/jphysiol.2001.012836","article-title":"Expression of P2X2 and P2X3 receptor subunits in rat carotid body afferent neurones: role in chemosensory signalling","volume":"537","author":"Prasad","year":"2001","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.autneu.2021.102859_bb0310","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0031-6997(24)01373-5","article-title":"Receptors for purines and pyrimidines","volume":"50","author":"Ralevic","year":"1998","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.autneu.2021.102859_bb0315","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1113\/jphysiol.2003.047944","article-title":"P2X2 subunits contribute to fast synaptic excitation in myenteric neurons of the mouse small intestine","volume":"552","author":"Ren","year":"2003","journal-title":"J. Physiol."},{"issue":"13","key":"10.1016\/j.autneu.2021.102859_bb0320","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/bph.14677","article-title":"Action of MK-7264 (gefapixant) at human P2X3 and P2X2\/3 receptors and in vivo efficacy in models of sensitisation","volume":"176","author":"Richards","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"36","key":"10.1016\/j.autneu.2021.102859_bb0325","doi-asserted-by":"crossref","first-page":"11315","DOI":"10.1523\/JNEUROSCI.23-36-11315.2003","article-title":"Pivotal role of nucleotide P2X2 receptor subunit of the ATP-gated ion channel mediating ventilatory responses to hypoxia","volume":"23","author":"Rong","year":"2003","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.autneu.2021.102859_bb0330","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01615-2019","article-title":"Gefapixant in two randomised dose-escalation studies in chronic cough","volume":"55","author":"Smith","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.autneu.2021.102859_bb0335","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S2213-2600(19)30471-0","article-title":"Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial","volume":"8","author":"Smith","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"5262","key":"10.1016\/j.autneu.2021.102859_bb0340","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.272.5262.735","article-title":"The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7)","volume":"272","author":"Surprenant","year":"1996","journal-title":"Science"},{"issue":"56","key":"10.1016\/j.autneu.2021.102859_bb0345","doi-asserted-by":"crossref","first-page":"pe6","DOI":"10.1126\/scisignal.256pe6","article-title":"Extracellular ATP in the immune system: more than just a \u201cdanger signal\u201d","volume":"2","author":"Trautmann","year":"2009","journal-title":"Sci. Signal."},{"issue":"3","key":"10.1016\/j.autneu.2021.102859_bb0350","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1113\/jphysiol.2003.060079","article-title":"Subtypes of vagal afferent C-fibres in Guinea-pig lungs","volume":"556","author":"Undem","year":"2004","journal-title":"J. Physiol."},{"issue":"6497","key":"10.1016\/j.autneu.2021.102859_bb0355","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/371516a0","article-title":"A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP","volume":"371","author":"Valera","year":"1994","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.autneu.2021.102859_bb0360","first-page":"283","article-title":"Characterization and chromosomal localization of a human P2X receptor from the urinary bladder","volume":"3","author":"Valera","year":"1995","journal-title":"Recept. Channels"},{"issue":"5","key":"10.1016\/j.autneu.2021.102859_bb0365","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1113\/jphysiol.2014.281014","article-title":"Postsynaptic P2X3-containing receptors in gustatory nerve fibres mediate responses to all taste qualities in mice","volume":"593","author":"Vandenbeuch","year":"2015","journal-title":"J. Physiol."},{"issue":"15","key":"10.1016\/j.autneu.2021.102859_bb0370","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1523\/JNEUROSCI.21-15-05670.2001","article-title":"P2X3 knock-out mice reveal a major sensory role for urothelially released ATP","volume":"21","author":"Vlaskovska","year":"2001","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.autneu.2021.102859_bb0375","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0028-3908(97)00126-3","article-title":"Immunohistochemical study of the P2X2 and P2X3 receptor subunits in rat and monkey sensory neurons and their central terminals","volume":"36","author":"Vulchanova","year":"1997","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.autneu.2021.102859_bb0380","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1046\/j.1460-9568.1998.00355.x","article-title":"P2X3 is expressed by DRG neurons that terminate in inner lamina II","volume":"10","author":"Vulchanova","year":"1998","journal-title":"Eur. J. Neurosci."},{"issue":"19","key":"10.1016\/j.autneu.2021.102859_bb0385","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1073\/pnas.1800907115","article-title":"Druggable negative allosteric site of P2X3 receptors","volume":"115","author":"Wang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.autneu.2021.102859_bb0390","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1046\/j.0953-816x.2001.01805.x","article-title":"Changes in P2X receptor responses of sensory neurons from P2X3-deficient mice","volume":"14","author":"Zhong","year":"2001","journal-title":"Eur. J. Neurosci."}],"container-title":["Autonomic Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070221000898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070221000898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:20:50Z","timestamp":1761567650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1566070221000898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":77,"alternative-id":["S1566070221000898"],"URL":"https:\/\/doi.org\/10.1016\/j.autneu.2021.102859","relation":{},"ISSN":["1566-0702"],"issn-type":[{"value":"1566-0702","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The discovery and development of gefapixant","name":"articletitle","label":"Article Title"},{"value":"Autonomic Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autneu.2021.102859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102859"}}